BAIKSAN Co., Ltd. Overview
| Field | Detail | Source |
|---|---|---|
| Legal name (Korean) | 주식회사 백산 ((주)백산) | [S3] |
| Legal name (English) | BAIKSAN CO.,LTD (exchange listings often show it as "BAIKSAN Co,. Ltd") | [S3][S6] |
| Former names | Baiksan Hwasung Industry (백산화성산업; original sole proprietorship); Baiksan Hwasung Co., Ltd. ((주)백산화성; incorporated entity). Renamed BAIKSAN Co., Ltd. in April 1998 | [S10][S21] |
| Founding year | 1984 (business founded as Baiksan Hwasung Industry, plant in Songpo-myeon, Goyang); incorporated 6 October 1986 | [S3][S10][S11] |
| Incorporation jurisdiction | Republic of Korea | [S3] |
| Headquarters | 47, Gongdan 1-daero 27beon-gil, Siheung-si, Gyeonggi-do 15086, Republic of Korea; tel. +82 31 499 0044 | [S3][S22] |
| Exchange / ticker | Korea Exchange, KOSPI (Securities Market); 035150 (035150.KS / KRX:035150) | [S1][S6] |
| Listing date | 1999 (Korea Stock Exchange) | [S11] |
| ISIN | confirm against KRX before use) | — |
| CUSIP | Not applicable (no US listing) | — |
| Fiscal year end | 31 December | [S1][S3] |
| Paid-in capital | KRW 14.15 bn (31 Dec 2025) | [S10] |
| Representative directors | Kim Han-jun and Jeon Je-hyung (each a separate representative director) | [S3][S10] |
| Employees (parent, latest) | 224 at FY2025 year-end (206 permanent, 18 contract); 215 at 30 June 2026 | [S3][S10] |
| Auditor | Not publicly disclosed in sources reviewed (stated in DART audit report attached to FY2025 business report) | — |
| Share price (15 Oct 2026 close) | KRW 10,070 (−4.1% on the day) | [S5] |
| Market capitalisation | About KRW 199 bn (KRW 10,070 × 19.77 m shares outstanding at 30 Jun 2026 [S7]). DataHero/Valueline shows KRW 207.6 bn, likely on a slightly higher share count. Butler shows KRW 205.4 bn at KRW 10,390 | [S1][S5][S7] |
| Website | http://www.baiksan.co.kr | [S3] |
| Industry classification | Textiles / Textile & Leather (KRX). Consumer Cyclical – Footwear & Accessories (Morningstar) | [S9b][S22] |
The entity profiled is the listed company matching the identification details supplied: BAIKSAN Co., Ltd. (Korean: 주식회사 백산), KOSPI ticker 035150, website www.baiksan.co.kr. No change of listing venue or legal identity since the details were compiled was found. The company remains listed on the KOSPI main board of the Korea Exchange under the same code [S1][S3].
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Employees (parent, persons) | 240 | 237 | 236 | 225 | 224 |
| Revenue per employee (parent, KRW bn) | 0.85 | 0.96 | 0.91 | 1.15 | 1.21 |
| Average annual salary (KRW m) | 45.43 | 52.82 | 50.26 | 57.13 | 53.52 |
Source: DART business reports FY2021–FY2025 compiled by ETFshopping [S3]. Headcount covers the Korean parent only; overseas plant workforces are not included. Other aggregators show different headcounts because they apply different scopes: S&P Global shows 202 [S9], TheVC shows 197 at June 2026 based on pension enrolment [S25], and JobKorea shows 215 at 30 June 2026 [S10].
BAIKSAN is a Korean family-controlled maker of polyurethane (PU) synthetic leather. Its core business is upper materials for global athletic footwear brands, chiefly Nike and Adidas. It also serves automotive interior and consumer-electronics accessory markets from plants in Korea, China, Indonesia, Vietnam and India.
Brokers and the financial press have long described it as the world's second-largest supplier of synthetic leather for sports footwear, behind Taiwan's San Fang Chemical.
The company had consolidated revenue of KRW 504.9 bn in FY2025. It also runs an apparel sewing subsidiary (Choishin Muslsan), a nonwoven materials affiliate (Baiksan Lintex) and a small venture-capital arm.
Its earnings are cyclical and tied to brand inventory cycles. Since 2022 it has paired that cyclicality with an aggressive shareholder-return programme. Combined dividends and buybacks equalled about 64% of FY2025 net income, and the share count fell from 24.2 m to 19.77 m between 2021 and mid-2026.
The stock trades at roughly 0.75x book value and about 5.6x trailing earnings. That valuation reflects customer concentration, controlling-family ownership near 62% and thin free float.
What the Company Does
BAIKSAN manufactures and sells synthetic leather made from polyurethane synthetic resin. The resin is applied to a substrate of knitted, woven or nonwoven fabric through foaming and coating processes. The company also produces resin and nonwoven fabric.
Morningstar summarises the company's own business description as follows [S22]. BAIKSAN and its subsidiaries produce synthetic leather using PU resin and nonwoven fabric. End uses include shoes, clothing, bags, balls, sporting goods, electronic product cases, furniture, automotive interior materials and miscellaneous goods, and demand broadens as new applications develop.
Investing.com's profile, sourced from S&P Capital IQ, describes the company as producing synthetic leather, resin and nonwoven fabric. It confirms the April 1998 change of name from Baiksan Hwasung [S21]. A third-party brand database adds two adjacent activities [S23b]:
-
nonwoven wipes for household and industrial cleaning and polishing
-
refining and recycling of waste solvents generated in synthetic-leather production
Business Model and Revenue Model
The revenue model is almost entirely product sales: manufactured material sold by the metre or square metre. No meaningful service, subscription or licensing revenue was identified. The consolidated group has three reported segments [S6]:
-
Synthetic Leather: the core manufacturing business. It made up about 77% of 2Q FY2026 revenue on a segment basis [S1].
-
Clothing: apparel sewing and production through subsidiary Choishin Muslsan (최신물산). It made up about 21% of 2Q FY2026 revenue [S1].
-
Other Investment: chiefly venture-capital and financial activities through BSK Investment. It made up about 2% [S1].
Value-Chain Position
BAIKSAN sits in the upstream materials tier of the athletic-footwear supply chain:
Inputs: PU resins, solvents (principally DMF, dimethylformamide, in solvent-based processes), base fabrics (knits, wovens, nonwovens) and pigments. Many of these are petroleum derivatives, so input costs track oil and chemical prices.
BAIKSAN's role: coating and finishing synthetic leather to the specifications of the brand (Nike, Adidas and others).
Customers of record: contract footwear manufacturers in Vietnam, Indonesia and China, such as Pou Chen and Feng Tay. They buy the material, but the brand nominates it.
End brand: the brand approves and designates the material supplier.
The UAnalyze write-up on San Fang describes this nomination model for the sector. The brand specifies the material, the shoemaker places the order, and this three-way arrangement lowers the risk of an individual supplier being displaced [S23]. The same structure applies to BAIKSAN. Its economic customer is the brand even when its invoice customer is a Vietnamese or Indonesian factory. This explains why the company co-locates plants near the brands' footwear assembly clusters.
Customer Types and End-Markets
| End-market | Description | Evidence |
|---|---|---|
| Sports footwear | Largest application; PU synthetic leather for shoe uppers. Brokers estimate Nike at about 47% and Adidas at about 35% of footwear-segment customer revenue (Daishin Securities, June 2024) | [S14] |
| Automotive interiors | Synthetic leather supplied to about 30 Hyundai Motor Group models (Hana Securities, January 2024). Small-volume supply to some models of an undisclosed global automaker "S" began in April 2023 | [S13] |
| Electronics cases / IT accessories | Historically a major supplier of synthetic leather for Apple iPad covers (from October 2010) and Samsung Galaxy Tab covers. Brokers in 2021 referred to a "global smartphone company A" as a customer | [S11][S12][S19] |
| Furniture, bags, balls, sporting goods, clothing | Smaller diversified applications | [S22] |
| Apparel (via Choishin Muslsan) | Garment sewing and production for apparel customers; customer names not publicly disclosed | [S6][S16] |
| Industrial / hygiene nonwovens (via Baiksan Lintex) | Industrial nonwovens and resins, plus hygiene materials such as sanitary-pad top sheets, cosmetic mask sheets, cleansing tissues and hospital poultice substrates | [S16] |
Application Mix
Hi Investment & Securities (May 2024) reported FY2023 sales by application as 61.7% sports footwear and 15.7% vehicle interior materials. The remainder was IT/electronics cases, other applications and clothing [S17]. Earlier broker data showed the mix in 3Q FY2020 as 73% sports footwear and 19% vehicle interiors on a synthetic-leather basis [S19]. Over that period, automotive's share grew and electronics cases declined.
Independent Characterisation
BAIKSAN is best understood as a specialist, brand-nominated material converter. The key indicators are:
-
concentrated customer power
-
moderate technology barriers (formulation, colour matching, consistency, brand restricted-substance compliance and qualification cycles)
-
commodity-linked input costs
Its competitive position rests on long qualification histories with Nike and Adidas, going back to 1986 [S11][S12]. It also rests on multi-country production close to footwear assembly hubs.
The automotive segment gives diversification into a market with longer product cycles. It also concentrates exposure on Hyundai-Kia. The clothing and investment subsidiaries add little strategic value. Historically they have diluted earnings, most visibly through Choishin Muslsan's losses in 2019–2020 [S18][S18b].
Margins have widened since the trough of 2020–2021. Analysts attribute the improvement to three factors [S17]:
-
operating leverage as volumes recovered
-
stable raw-material prices
-
headcount and fixed-cost reductions, including the sale of a Vietnam plant around 2020 [S18c]
Strategy
Stated Corporate Strategy
| Strategic theme | Evidence | Source |
|---|---|---|
| Deepen share with core footwear brands | Hana Securities (Jan 2024) said Nike had been rebalancing its supply chain toward Korean suppliers and expected BAIKSAN to become Nike's number-one internal synthetic-leather supplier in 2024 | [S13] |
| Automotive diversification and globalisation | About 30 Hyundai Motor Group models supplied. Small-volume supply to global automaker "S" since Apr 2023. Hana estimated wider adoption could add more than KRW 200 bn a year in automotive sales (broker projection, not company guidance) | [S13] |
| Production close to footwear clusters | Indonesia build-out; Vietnam re-entry; India subsidiary | [S3][S7][S10] |
| Sustainable materials | Water-dispersible microporous PU technology; national R&D projects in biomass, bio-chemical and fine-chemical materials (2023); lyocell collaboration through Lintex | [S10][S16][S25] |
| Shareholder value enhancement | Recurring buybacks and cancellations since 2022; interim dividends since 2023; capital-reserve reduction for tax-free dividends (Mar 2026) | [S2][S3] |
BAIKSAN does not publish an English-language annual report, investor-day materials or medium-term plan in the sources reviewed. No formal "Corporate Value-up Plan" disclosure under the Korea Exchange programme was identified for BAIKSAN. (A value-up document that appeared in search results belonged to another company, Partron, and has been excluded.) Strategic themes are therefore inferred from the business report, capital-allocation actions and broker commentary.
Initiatives Announced or Executed in the Last 24 Months (Oct 2024–Oct 2026)
| Date | Initiative | Detail | Source |
|---|---|---|---|
| FY2024–FY2025 | Capacity investment | Capex of KRW 37.3 bn (FY2024) and KRW 10.6 bn (FY2025). Land, buildings and machinery up materially. Indonesian subsidiary in ramp-up | [S3][S7][S8] |
| 2,025 | Buybacks | KRW 12.3 bn of shares repurchased in FY2025 | [S8] |
| 15 Sep 2025 | Interim dividend | KRW 150 per share | [S2] |
| 12 Feb 2026 | Year-end dividend | KRW 300 per share (KRW 6.1 bn), +50% YoY | [S2] |
| 27 Mar 2026 | Capital-reserve reduction approved | Enables tax-free dividends to individual shareholders; not yet used for a tax-free payout | [S2] |
| 10 Apr 2026 | Treasury cancellation decision | KRW 3.7 bn | [S2] |
| 13 May 2026 | Treasury acquisition decision | KRW 2.8 bn | [S2] |
| 23 Jun 2026 | Treasury cancellation decision | KRW 2.8 bn (257,762 common shares) | [S2][S25] |
| 15 Sep 2026 | Interim dividend | KRW 250 per share (KRW 4.9 bn), +66.7% YoY | [S2] |
Cost Programmes and Sustainability Commitments
Cost programmes: no formal programme with quantified targets has been disclosed. The last documented restructuring was around 2020, involving the Vietnam plant sale and headcount cuts [S18c]. Parent payroll as a share of separate revenue fell from 5.3% (FY2021) to 4.4% (FY2025) [S3].
Sustainability commitments: no quantified emissions or ESG targets are publicly disclosed.
Medium-Term Financial Targets and Guidance
Management has not publicly disclosed revenue, margin or capital-return targets in the sources reviewed. Korean small caps rarely issue numerical guidance.
Products & Services
BAIKSAN does not publish a public product catalogue with SKU-level specifications, launch years or pricing. Product names, technical data sheets and price lists are not publicly disclosed. The portfolio below is reconstructed from regulatory descriptions, the company history, press coverage and broker reports.
Synthetic Leather Segment
| Product line | Description | Key capabilities / specifications | Target customer | Launch / latest version | Pricing model |
|---|---|---|---|---|---|
| PU synthetic leather for athletic footwear uppers | Core product; PU-coated base fabrics for shoe uppers, overlays and trims | Colour matching, abrasion and flex resistance, brand restricted-substance compliance; detailed specifications not disclosed | Nike, Adidas and historically Reebok, Puma, New Balance, Asics; contract shoemakers in Vietnam, Indonesia and China | Since 1986 (Adidas/Nike) | Per-metre B2B pricing; not disclosed |
| Nonwoven-based artificial leather (부직포인공피혁) | Artificial leather on nonwoven substrates, closer to genuine-leather hand feel | — | Footwear, goods | — | — |
| Water-dispersible microporous PU synthetic leather | Waterborne urethane synthetic leather with micropores; lower-solvent process | Breathability (micropores); reduced solvent use | Brands with sustainability targets | Introduced (date not disclosed) | — |
| Automotive interior synthetic leather | PU synthetic leather for vehicle interiors (seats and trims; part-level detail not disclosed) | OEM durability, fogging, flammability and light-fastness standards (specific test regimes not disclosed) | Hyundai Motor Group (about 30 models as of Jan 2024); undisclosed global automaker "S" (small volume since Apr 2023) | Automotive diversification from c. 2012 | Programme-based supply contracts; not disclosed |
| Electronics case materials | Synthetic leather for tablet and smartphone covers and cases | Thin-gauge, premium surface finishes | Apple (iPad cases from Oct 2010; iPad 2 cover leather from Feb 2011), Samsung (Galaxy Tab covers), "global smartphone company A" | 2010 onwards | — |
| General goods synthetic leather | Synthetic leather for bags, balls, sporting goods, furniture, clothing | — | Goods and furniture makers | Long-standing | — |
| Resins | PU synthetic resins (partly for captive use) | — | Internal; external customers not disclosed | — | — |
| Nonwoven wipes | Cleaning and polishing wipes for household and industrial use | — | Household and industrial users | — | — |
| Solvent recovery | Refining and recycling of waste solvents from synthetic-leather production | Supports cost and environmental performance | Internal use (possible external sales not disclosed) | — | — |
Sources: [S10][S11][S12][S13][S19][S22][S23b].
Baiksan Lintex (Affiliate, 76.47%)
| Product line | Description | Target customer | Source |
|---|---|---|---|
| Industrial nonwovens | Nonwovens for apparel and industrial uses, some supplied to BAIKSAN | BAIKSAN group; industrial customers | [S16] |
| Hygiene material substrates | Sanitary-pad top sheets, cosmetic mask-pack sheets, cleansing tissues, medical poultice substrates; patented technologies held in this area | Hygiene and cosmetics manufacturers | [S16] |
| Resins | Resin products | — | [S16] |
| Lyocell R&D | Joint research on lyocell fibre under a 2019 MOU with a Chinese green-fibre producer | Future sustainable materials | [S16] |
Clothing Segment (Choishin Muslsan)
| Product line | Description | Target customer | Source |
|---|---|---|---|
| Apparel sewing / OEM production | Garment sewing and production services | Apparel brands (names not disclosed) | [S16][S18b] |
| Apparel distribution | Distribution activities as described at acquisition | — | [S16] |
Other Investment Segment
| Offering | Description | Source |
|---|---|---|
| BSK Investment | Venture-capital management, including BSK No. 11 Next Unicorn fund | [S3] |
| Strategic minority stakes | BS Research (bio), Gifted MS (business not disclosed) | [S3][S15] |
Flagship Offerings
No branded flagship product names are publicly disclosed. Investors and brokers treat athletic-footwear upper synthetic leather supplied to Nike and Adidas as the flagship franchise. Hyundai Motor Group automotive interior leather is treated as the strategic growth franchise [S13][S14].
Financial Narrative
Basis: K-IFRS consolidated statements, fiscal years ending 31 December. Reported revenue, operating income and net income come from DART filings via Butler/ETFshopping [S1][S18b]. Other lines come from S&P Global via StockAnalysis [S6][S7][S8], with selected FY2025 detail from DataHero/Valueline [S5]. Where line items differ, the discrepancy is noted.
Income Statement
Notes:
Operating income: S&P figures differ slightly from reported: 24.3 / 49.8 / 52.6 / 76.7 / 53.8 [S6].
Pre-tax income: is derived as S&P pre-tax margin × revenue. FY2025 is confirmed at KRW 48.0 bn by DataHero [S5].
EBITDA: DataHero reports FY2025 EBITDA of KRW 59.9 bn [S5], against KRW 61.8 bn computed here. The difference comes from D&A definitions.
EPS: DataHero reports FY2025 EPS of KRW 1,585 [S5].
Diluted EPS: is not separately disclosed in the sources reviewed. No material dilutive instruments were identified, so diluted EPS is expected to approximate basic EPS.
DPS: is the sum of interim and year-end dividends declared for the fiscal year [S2][S6].
Margin Profile
Calculated data [S1][S6].
Revenue CAGR FY2021–FY2025: about 8.0% a year (KRW 371.1 bn to KRW 504.9 bn).
Operating income CAGR FY2021–FY2025: about 23.3% a year, distorted by the depressed FY2021 base.
Quarterly Trajectory (Most Recent Six Quarters)
Sources: quarterly filings via ETFshopping [S4]. 4Q25 is derived as FY2025 minus 9M FY2025. Trailing-twelve-month totals to June 2026 cross-check exactly with S&P TTM data: revenue KRW 505.2 bn and operating income KRW 49.3 bn [S6].
YoY changes reported [S4]:
-
1Q25: revenue +12.7%, operating income −6.0%
-
2Q25: revenue +5.7%, operating income −21.0%
-
3Q25: revenue +4.3%, operating income −29.0%
-
1Q26: revenue −3.1%, operating income −33.4%
-
2Q26: revenue +3.6%, operating income +14.4%, net income +37.3%
1H FY2026 versus 1H FY2025: revenue flat (KRW 256.6 bn vs KRW 256.3 bn). Operating income down about 13% (KRW 29.0 bn vs KRW 33.3 bn).
Balance Sheet
Source: S&P Global via StockAnalysis [S7].
Latest balance sheet (30 June 2026) [S7]:
-
cash and short-term investments: KRW 57.1 bn
-
total debt: KRW 108.1 bn
-
net debt: KRW 51.0 bn
-
total equity: KRW 273.0 bn
-
total assets: KRW 455.5 bn
-
book value per share: KRW 13,661
-
shares outstanding: 19.77 m
PP&E composition shift [S7]:
-
Land rose from KRW 49.7 bn (FY2023) to KRW 76.0 bn (FY2025).
-
Buildings rose from KRW 28.6 bn to KRW 65.9 bn.
-
Machinery rose from KRW 47.1 bn to KRW 91.9 bn.
-
Construction in progress peaked at KRW 32.8 bn in FY2024.
This is consistent with a significant plant build-out in FY2024–FY2025. The specific site is not publicly identified in the sources reviewed. The concurrent start-up losses at PT Baiksan Indonesia suggest Indonesia is the main location.
Cash Flow
Source: S&P Global via StockAnalysis [S8]. FCF = OCF − capex. TTM to June 2026 [S8]:
-
operating cash flow: KRW 36.2 bn
-
capex: KRW 7.6 bn
-
free cash flow: KRW 28.6 bn
-
buybacks: KRW 16.3 bn
-
dividends paid: KRW 9.3 bn
Return and Efficiency Ratios
Calculation basis (all derived from [S1][S6][S7][S8]):
ROE: net income attributable to owners ÷ average owners' equity.
ROA: total net income ÷ average total assets. FY2021 uses year-end assets.
ROIC: NOPAT ÷ year-end invested capital (equity + total debt − cash and short-term investments). NOPAT applies the effective tax rate derived from pre-tax and net income.
Interest coverage: uses cash interest paid because interest expense is disclosed in the sources only for FY2025 (KRW 4.71 bn, giving 11.4x on an accrual basis).
Working-capital days: use year-end balances, revenue for DSO, and cost of sales for DIO and DPO.
Commentary on Trends, Inflections and Drivers
FY2021 — post-COVID recovery, held back by subsidiaries. Revenue fell 3.1% to KRW 371.1 bn, while operating income recovered from about KRW 4.0 bn in FY2020 to KRW 23.2 bn [S1][S18b]. Brokers had expected far more: Hana Securities forecast operating income of KRW 44–45 bn in April–July 2021 [S18b]. The shortfall points to further subsidiary charges and cost pressures from rising synthetic-resin prices, which Hana flagged in July 2021 [S18b].
Operating cash flow collapsed to KRW 9.8 bn because of a KRW 9.8 bn inventory build and other working-capital outflows [S8]. FY2021 is therefore the low-quality base year of the series.
FY2022 — volume-led inflection. Revenue rose 28.2% to KRW 475.9 bn and operating income more than doubled to KRW 50.3 bn [S1]. Synthetic Leather segment revenue grew 31.6% [S6], consistent with footwear restocking and Nike's continued vendor consolidation.
Operating cash flow recovered to KRW 51.6 bn, helped by an inventory release of KRW 10.5 bn [S8]. The company used this cash to start buybacks (KRW 9.9 bn) and to cut gross debt by KRW 16.4 bn [S8].
FY2023 — revenue down, margins up. Revenue fell 12.2% to KRW 417.7 bn as global sportswear brands worked down excess inventory and Adidas orders weakened [S14][S17]. Despite this, operating income rose 5.6% to KRW 53.1 bn and gross margin widened to 22.9% from 19.9%. Hi Investment attributed the improvement to stabilising raw-material prices [S17].
The Clothing segment contracted 28.4% [S6]. Net debt fell to a five-year low of KRW 11.0 bn [S7].
FY2024 — record year. Revenue rose 19.0% to KRW 497.0 bn and operating income reached a record KRW 76.5 bn (15.4% margin) [S1]. Gross margin peaked at 25.8% [S6].
Brokers credited three drivers [S13][S14]:
-
recovery in Adidas orders
-
BAIKSAN's rising share of Nike's synthetic-leather purchases (Hana expected it to become Nike's number-one internal supplier in 2024)
-
automotive growth
Capital intensity rose sharply. Capex reached KRW 37.3 bn, long-term debt rose to KRW 32.3 bn and PP&E grew 55% [S7][S8]. Receivables jumped to KRW 91.3 bn [S7]. Free cash flow fell to KRW 19.0 bn despite record earnings.
FY2025 — flat sales, profit compression. Revenue rose 1.6% to KRW 504.9 bn, but operating income fell 30% to KRW 53.6 bn and net income fell 45% to KRW 33.2 bn [S1].
The quarterly sequence shows steady deterioration, with operating margin falling from 14.2% in 1Q25 to 6.5% in 4Q25 [S4]. Identifiable drivers include:
Lower gross margin: (21.7% vs 25.8%). Raw materials alone were KRW 279.7 bn, or 55% of revenue [S5].
Higher depreciation: (D&A up from KRW 6.0 bn to KRW 8.2 bn) as new capacity came on stream [S8].
PT Baiksan Indonesia's KRW 10.8 bn net loss: [S3].
A higher effective tax rate: of about 30.8% [S5].
Losses at BS Research and Choishin: [S3].
Free cash flow improved to KRW 27.8 bn as capex normalised to KRW 10.6 bn [S8].
1H FY2026 — stabilisation. 1Q26 operating income fell 33.4% YoY to KRW 12.7 bn. 2Q26 recovered to KRW 16.3 bn (+14.4% YoY, 12.9% margin) [S4].
Net debt rose to KRW 51.0 bn at 30 June 2026 [S7]. Three factors drove this:
-
shareholder returns (TTM buybacks KRW 16.3 bn and dividends KRW 9.3 bn)
-
a KRW 20.1 bn TTM working-capital build, with receivables up to KRW 98.0 bn and inventory up to KRW 73.8 bn
-
capex [S7][S8]
Balance-sheet quality. Leverage is moderate (debt/equity 0.43x, net debt/EBITDA about 0.6x at FY2025). Most debt is short-term trade-related borrowing that rolls over within the year: KRW 56.1 bn of short-term debt was issued and KRW 68.7 bn repaid in FY2025 [S8]. Book value per share has doubled in four years, from KRW 6,016 (FY2021) to KRW 12,580 (FY2025) [S7]. Earnings retention and buybacks below book value both contributed.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | What it contains (as understood from disclosures) | Products / services |
|---|---|---|
Synthetic Leather | Parent company (Siheung, Korea) and manufacturing subsidiaries in China (Dongguan Baiksan), Indonesia (PT Baiksan Indonesia), Vietnam (Baiksan Vietnam, Baiksan Textile) and India (Baiksan Synthetic India). | PU synthetic leather for footwear, automotive, electronics cases, furniture and goods; nonwoven-based artificial leather; resins; nonwovens |
Clothing | Choishin Muslsan Co., Ltd. (96.03% owned) | Garment sewing and production, apparel distribution |
Other Investment | BSK Investment (96.26%) and its funds, including BSK No. 11 Next Unicorn Investment Association (5.6%). | Venture capital and financial investment income |
Segment revenue (KRW Bn)
| Segment revenue (KRW Bn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Synthetic Leather | 334.0 | 439.6 | 423.9 | 522.9 | 490.1 |
Clothing | 107.9 | 114.6 | 82.0 | 85.3 | 94.0 |
Other Investment | 9.0 | 4.6 | 4.3 | 11.8 | 7.7 |
Adjustment and Elimination | -79.9 | -83.0 | -92.5 | -123.0 | -86.8 |
Consolidated Revenue | 371.1 | 475.9 | 417.7 | 497.0 | 504.9 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Segment metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Synthetic Leather YoY growth (%) | 0 | 31.6 | -3.6 | 23.4 | -6.3 |
Clothing YoY growth (%) | 0 | 6.2 | -28.4 | 4.0 | 10.2 |
Synthetic Leather share of gross segment revenue (%) | 74.0 | 78.8 | 83.1 | 84.3 | 82.8 |
Clothing share of gross segment revenue (%) | 23.9 | 20.5 | 16.1 | 13.8 | 15.9 |
Other Investment share of gross segment revenue (%) | 2.0 | 0.8 | 0.8 | 1.9 | 1.3 |
Group Entities
| Entity | Country | Ownership (%) | Total assets (KRW Bn) | Net income (KRW Bn) | Function |
|---|---|---|---|---|---|
P.T. BAIKSAN INDONESIA | Indonesia | 99.95 | 85.9 | -10.8 | Synthetic-leather manufacturing |
Choishin Muslsan Co., Ltd. (최신물산㈜) | Korea | 96.03 | 44.5 | -1.58 | Apparel sewing and production |
DONGGUAN BAIKSAN CO., LTD | China | 100 | 38.8 | 10.4 | Synthetic-leather manufacturing |
BSK Investment Co., Ltd. (㈜BSK인베스트먼트) | Korea | 96.26 | 27.0 | 1.91 | Venture capital |
Baiksan Art & Network Co., Ltd. (㈜백산아트앤네트워크) | Korea | 100 | 5.81 | -0.075 | — |
Baiksan Lintex Co., Ltd. ((주)백산린텍스) | Korea | 76.47 | 28.5 | 3.02 | Industrial and hygiene nonwovens, resins |
BAIKSAN VIETNAM CO., LTD | Vietnam | 100 | 12.6 | -0.02 | Manufacturing (details not disclosed) |
BS Research Co., Ltd. (㈜비에스리서치) | Korea | 48.24 | 5.6 | -2.28 | Bio-related research (per press) |
BAIKSAN TEXTILE CO., LTD | Vietnam | 100 | 2.47 | 0.47 | Textiles / nonwovens (Trang Bang IZ, Tay Ninh per trade data) |
BSK No. 11 Next Unicorn Investment Association | Korea | 5.6 | — | — | VC fund |
Gifted MS Co., Ltd. ((주)기프티드엠에스) | Korea | 33.33 | 2.12 | -1.28 | — |
Baiksan Synthetic India Pvt Ltd | India | 99.99998 | 4.74 | 0.82 | Synthetic-leather operations in India |
“—” = not publicly disclosed.
Income Statement and Margin Analysis (%)
| Metric (KRW Bn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue | 371.1 | 475.9 | 417.7 | 497.0 | 504.9 |
Revenue growth YoY (%) | -3.1 | 28.2 | -12.2 | 19.0 | 1.6 |
Cost of sales | 304.0 | 381.4 | 321.9 | 368.8 | 395.5 |
Gross profit | 67.1 | 94.5 | 95.8 | 128.2 | 109.5 |
Operating income (reported) | 23.2 | 50.3 | 53.1 | 76.5 | 53.6 |
Depreciation and amortisation (cash-flow basis) | 5.9 | 6.4 | 5.9 | 6.0 | 8.2 |
EBITDA (operating income + D&A) | 29.1 | 56.7 | 59.0 | 82.5 | 61.8 |
Pre-tax income | 29.2 | 54.8 | 51.9 | 81.1 | 48.0 |
Net income (total) | 19.1 | 44.9 | 40.5 | 59.9 | 33.2 |
Net income attributable to owners | 19.2 | 45.3 | 41.3 | 60.7 | 33.5 |
EPS basic (KRW) | 794 | 1,878 | 1,802 | 2,764 | 1,579 |
Dividend per share (KRW) | 100 | 150 | 300 | 350 | 450 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBusiness Lines
| Line | Value |
|---|---|
Revenue | 504.92 (domestic 198.44; export 306.47) |
Cost of sales | 394.89 |
— of which raw materials | 279.66 |
— of which labour | 44.73 |
— of which depreciation | 5.16 |
Gross profit | 110.02 |
SG&A | 56.42 |
— salaries | 19.64 |
— commissions | 10.25 |
— freight | 9.25 |
— bad-debt expense | 1.47 |
— depreciation | 3.00 |
Operating income | 53.60 |
Financial income | 8.15 |
Financial costs | 11.32 (interest expense 4.71) |
Other non-operating income | 11.40 |
Other non-operating expenses | 13.33 |
Equity-method loss | 0.55 |
Pre-tax income | 47.95 |
Income tax | 14.76 (effective rate about 30.8%) |
Net income | 33.19 |
Net income attributable to owners | 33.50 |
Margin (%)
| Margin (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin | 18.1 | 19.9 | 22.9 | 25.8 | 21.7 |
Operating margin | 6.3 | 10.6 | 12.7 | 15.4 | 10.6 |
EBITDA margin | 7.8 | 11.9 | 14.1 | 16.6 | 12.2 |
Pre-tax margin | 7.9 | 11.5 | 12.4 | 16.3 | 9.5 |
Net margin | 5.1 | 9.4 | 9.7 | 12.1 | 6.6 |
Quarter Metric Details
| Quarter metric (KRW Bn) | 1Q25 | 2Q25 | 3Q25 | 4Q25 | 1Q26 | 2Q26 |
|---|---|---|---|---|---|---|
Revenue | 134.2 | 122.1 | 134.4 | 114.2 | 130.1 | 126.5 |
Operating income | 19.0 | 14.3 | 12.9 | 7.4 | 12.7 | 16.3 |
Net income | 13.1 | 6.6 | 9.0 | 4.5 | 12.9 | 9.1 |
Operating margin (%) | 14.2 | 11.7 | 9.6 | 6.5 | 9.8 | 12.9 |
Balance Sheet and Per-Share Data
| Balance sheet (KRW Bn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cash and equivalents | 65.4 | 46.7 | 47.4 | 65.5 | 62.9 |
Short-term investments | 5.4 | 20.5 | 23.2 | 9.7 | 9.9 |
Accounts receivable | 69.2 | 74.0 | 69.3 | 91.3 | 83.1 |
Inventory | 62.5 | 52.2 | 52.9 | 67.8 | 66.7 |
Total current assets | 209.8 | 204.3 | 208.0 | 252.5 | 239.7 |
Property plant and equipment | 80.0 | 89.5 | 95.0 | 147.5 | 170.2 |
Goodwill and intangibles | 3.5 | 3.1 | 3.5 | 5.9 | 5.9 |
Total assets | 330.2 | 338.9 | 351.9 | 457.9 | 446.7 |
Short-term debt incl current portion of LT debt | 80.9 | 84.1 | 71.8 | 76.6 | 65.2 |
Long-term debt | 19.4 | 1.3 | 1.6 | 32.3 | 38.2 |
Lease liabilities (current plus non-current) | 10.2 | 9.0 | 8.2 | 8.6 | 7.9 |
Total debt incl leases | 110.5 | 94.4 | 81.6 | 117.5 | 111.3 |
Net debt (total debt minus cash and ST investments) | 39.7 | 27.3 | 11.0 | 42.2 | 38.5 |
Total liabilities | 183.1 | 158.7 | 143.5 | 206.9 | 185.2 |
Shareholders equity (total) | 147.0 | 180.2 | 208.5 | 251.0 | 261.5 |
Equity attributable to owners | 145.6 | 178.5 | 206.1 | 248.1 | 258.6 |
Working capital | 61.6 | 58.9 | 78.8 | 90.7 | 104.9 |
Book value per share (KRW) | 6,016 | 7,626 | 9,159 | 11,538 | 12,580 |
Cash flow (KRW Bn)
| Cash flow (KRW Bn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow | 9.8 | 51.6 | 46.3 | 56.2 | 38.4 |
Capital expenditure | 4.3 | 28.5 | 10.6 | 37.3 | 10.6 |
Free cash flow | 5.5 | 23.1 | 35.7 | 19.0 | 27.8 |
Dividends paid | 2.4 | 2.4 | 5.8 | 7.7 | 7.4 |
Share repurchases | 0.0 | 9.9 | 7.5 | 17.3 | 12.3 |
Net debt issued (repaid) | -4.3 | -16.4 | -13.8 | 3.2 | -6.6 |
Change in working capital | -8.2 | -4.9 | -7.4 | -16.1 | -1.6 |
Cash interest paid | 2.4 | 3.0 | 3.9 | 3.9 | 4.7 |
Cash income tax paid | 8.0 | 10.3 | 11.9 | 16.5 | 22.4 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 13.2 | 28.1 | 21.5 | 26.7 | 13.2 |
ROA (%) | 5.8 | 13.4 | 11.7 | 14.8 | 7.3 |
ROIC (%) | 8.1 | 19.9 | 18.9 | 19.3 | 12.4 |
Current ratio (x) | 1.42 | 1.41 | 1.61 | 1.56 | 1.78 |
Debt to equity (x) | 0.75 | 0.52 | 0.39 | 0.47 | 0.43 |
Net debt to EBITDA (x) | 1.36 | 0.48 | 0.19 | 0.51 | 0.62 |
Interest coverage (operating income / cash interest, x) | 9.6 | 16.8 | 13.6 | 19.6 | 11.4 |
Asset turnover (x) | 1.12 | 1.42 | 1.21 | 1.23 | 1.12 |
Days sales outstanding | 68.0 | 56.8 | 60.6 | 67.1 | 60.0 |
Days inventory outstanding | 75.1 | 50.0 | 60.0 | 67.2 | 61.5 |
Days payables outstanding | 59.5 | 41.1 | 47.6 | 53.6 | 44.4 |
Cash conversion cycle (days) | 83.6 | 65.7 | 73.0 | 80.7 | 77.1 |
Revenue by destination (KRW Bn)
| Revenue by destination (KRW Bn) | FY2025 | LTM to Jun 2026 |
|---|---|---|
Domestic (Korea) | 198.4 | 203.4 |
Export | 306.5 | 301.7 |
Total | 504.9 | 505.2 |
Export share (%) | 60.7 | 59.7 |
Region (By Production / Entity) Overview
| Region (by production / entity) | Evidence | Direction |
|---|---|---|
Korea (Siheung HQ plant) | Parent revenue KRW 271.4 bn in FY2025 (separate basis) | Stable; includes automotive and exports |
China (Dongguan) | Profitable: net income KRW 10.4 bn FY2025 | Mature; serves China-based footwear and electronics supply chains |
Indonesia | Net loss KRW 10.8 bn FY2025 on assets of KRW 85.9 bn | Growth investment / ramp-up |
Vietnam (Baiksan Vietnam, Baiksan Textile) | Small asset bases (KRW 12.6 bn and KRW 2.5 bn) | Rebuilt presence after c. 2020 plant sale |
India (Baiksan Synthetic India) | Assets KRW 4.7 bn; net income KRW 0.8 bn | Early-stage; follows footwear sourcing shift to India |
Share price data
| Share price data | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Year-end share price (KRW, approx) | 7,463 | 7,538 | 10,101 | 12,821 | 13,060 |
Year-end market cap (KRW Bn, approx) | 180.6 | 176.5 | 227.3 | 275.6 | 268.5 |
DPS (KRW) | 100 | 150 | 300 | 350 | 450 |
Dividend yield at year-end (%) | 1.34 | 1.99 | 2.97 | 2.73 | 3.45 |
Share Price
| Recent closing prices (KRW) | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 | 15 Oct 2026 |
|---|---|---|---|---|---|---|
Share price | 14,880 | 14,350 | 13,060 | 12,660 | 9,660 | 10,070 |
Valuation Multiples
| Multiple | BAIKSAN | San Fang (1307.TW) | Duksung (004830.KS) |
|---|---|---|---|
P/E (trailing, x) | 5.6 | 9.2 | 15.3 |
P/E (forward, x) | about 4.2 | — | — |
EV/EBITDA (x) | 4.3 | 5.4 | — |
EV/Sales (x) | 0.50 | 1.01 | — |
P/B (x) | 0.74 | — | 0.56 |
Dividend yield (TTM DPS 550, %) | 5.5 | — | 3.6 |
“—” = not publicly disclosed.
Capital Markets
| Item | Value | Source |
|---|---|---|
Consensus target price | KRW 17,000 (2 brokers) | [S1] |
Implied upside vs KRW 10,070 | about +69% | Derived |
Forward P/E (consensus) | 4.18x at KRW 10,390, implying forward EPS of about KRW 2,486 and owners' net income of about KRW 49 bn at 19.77 m shares | [S1], derived |
Historical broker targets | Hana Securities KRW 21,300 (2024); Hana KRW 17,400 (Jul 2021); KRW 16,500 (Apr 2021) | [S18b] |
Dividend metric
| Dividend metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Interim DPS (KRW) | 0 | 0 | 100 | 150 | 150 |
Year-end DPS (KRW) | 100 | 150 | 200 | 200 | 300 |
Total DPS (KRW) | 100 | 150 | 300 | 350 | 450 |
Total dividends declared (KRW Bn) | 2.4 | 3.5 | 6.8 | 7.5 | 9.3 |
Share buybacks (KRW Bn) | 0.0 | 9.9 | 7.5 | 17.3 | 12.3 |
Total shareholder return (KRW Bn) | 2.4 | 13.4 | 14.3 | 24.8 | 21.6 |
Dividend payout ratio (%) | 13 | 8 | 16 | 12 | 28 |
Total return ratio (%) | 13 | 30 | 35 | 41 | 64 |
Shares outstanding (m)
| Shares outstanding (m) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | 1H26 |
|---|---|---|---|---|---|---|
Common shares outstanding | 24.20 | 23.41 | 22.50 | 21.50 | 20.56 | 19.77 |
Debt maturity (KRW Bn)
| Debt maturity (KRW Bn) | FY2025 |
|---|---|
Short-term borrowings (under 1 year) | 64.4 |
Current portion of long-term debt | 0.8 |
Current lease liabilities | 1.5 |
Long-term debt (over 1 year) | 38.2 |
Non-current lease liabilities | 6.4 |
Total debt incl leases | 111.3 |
Analyst Conclusions
Management Guidance
None is publicly disclosed. BAIKSAN does not issue numerical revenue, margin or capital-return guidance in the sources reviewed.
Consensus Expectations
The consensus target price is KRW 17,000 from 2 brokers. The forward P/E of 4.18x implies forward EPS of about KRW 2,486, or about KRW 49 bn of owners' net income [S1]. That would be about 40% above TTM owners' net income of KRW 35.5 bn [S6].
Detailed consensus revenue and operating income forecasts are not publicly disclosed in the sources reviewed. Thin coverage makes the consensus fragile.
Bull Case
-
Deep value with cash returns.
-
At about 0.74x book value, 5.6x trailing earnings and 4.3x EV/EBITDA, the stock prices in persistent decline.
-
Yet the company has earned 13–28% ROE in each of the last five years.
-
It pays a TTM dividend yield of about 5.5% and keeps cancelling shares (24.2 m to 19.77 m since FY2021).
-
At a KRW 9.3 bn dividend run-rate plus KRW 10–17 bn of annual buybacks, total shareholder yield is about 10–13% of market cap.
-
-
Earnings trough may have passed.
-
2Q26 operating income rose 14.4% YoY to KRW 16.3 bn, with a 12.9% margin, the first YoY gain since 4Q24.
-
If Indonesia moves from a KRW 10.8 bn loss toward breakeven, the swing alone is worth about one-third of FY2025 net income.
-
-
Structural share gains and diversification.
-
Brokers report rising share within Nike and an Adidas recovery.
-
Automotive is anchored by about 30 Hyundai-Kia models and an initial global OEM.
-
These could lift mid-cycle operating income back toward the KRW 70–75 bn achieved in FY2024 on a larger asset base.
-
Bear Case
-
Profitability reset rather than trough.
-
Gross margin fell from 25.8% to 21.7% in FY2025, and 4Q25 operating margin was only 6.5%.
-
FY2024 may have been a cyclical peak that combined brand restocking with benign raw-material prices.
-
If gross margin settles around 21–22%, operating income of KRW 50–55 bn is the realistic run-rate.
-
-
Capital intensity is eroding returns.
-
PP&E roughly doubled from KRW 95 bn (FY2023) to KRW 170 bn (FY2025), but operating income fell.
-
ROIC dropped from 19.3% to 12.4%.
-
Net debt rose to KRW 51 bn by mid-2026 while the company kept funding buybacks.
-
A KRW 20 bn TTM working-capital build compounds the pressure.
-
-
Concentration and governance cap the multiple.
-
Two brands drive about 82% of footwear revenue.
-
The family controls 61.88% and VIP holds 15.16%.
-
Free float near 20% and minimal investor communication may keep the stock structurally discounted regardless of earnings.
-
Key Catalysts and Monitorables (Next 12 Months)
| Expected timing | Catalyst / monitorable | What to watch |
|---|---|---|
| Mid-Nov 2026 | 3Q26 results | Whether YoY operating-income growth continues (3Q25 base KRW 12.9 bn) |
| Dec 2026 | Year-end dividend record date (expected 31 Dec) | Size of year-end DPS; first tax-free dividend from the capital-reserve reduction |
| Feb–Mar 2027 | FY2026 results and FY2026 business report | Indonesia subsidiary P&L; Choishin; segment margins; capex plan |
| Ongoing | Treasury-share actions | Further cancellations; response to Commercial Act reforms |
| Ongoing | Nike and Adidas order cycle and inventory commentary | Footwear volumes; vendor allocation |
| Ongoing | Automotive programme wins | Expansion with the global OEM; Hyundai-Kia model coverage |
| Ongoing | Raw-material prices and KRW/USD | Gross-margin direction |
| Ongoing | Competitor capacity (Duksung Indonesia, San Fang) | Pricing pressure in Southeast Asia |
| Ongoing | Controlling-shareholder purchases | Further stake increases (61.88% at Aug 2026) |
Concluding Analyst Verdict
BAIKSAN is a competent, cash-generative specialist that is mispriced for reasons partly within its control. The core franchise is real. It has supplied synthetic leather for Nike and Adidas footwear for four decades, brokers consistently rank it as the global number two in its niche, and it has earned double-digit ROE in each of the past five years.
The financial record since 2021 shows two things clearly:
Operating leverage when brand cycles turn: Operating income rose from KRW 23 bn to KRW 77 bn in three years.
Disciplined capital return: The share count fell 18%, DPS rose 4.5 times, and the total return ratio reached 64% of FY2025 net income.
The FY2025 setback is equally real. Margins compressed, Indonesia lost KRW 10.8 bn, and a heavy FY2024 capex cycle has not yet produced returns. With PP&E up about 80% since FY2023 and operating income lower, the burden of proof now sits with management.
At about 0.74x book and about 4.3x EV/EBITDA, the market is effectively pricing BAIKSAN as a no-growth, governance-discounted cyclical. Three developments would justify a re-rating toward the consensus target of KRW 17,000:
-
Confirmation that 2Q26 marked the earnings trough, through continued YoY growth in 3Q–4Q26.
-
Indonesian breakeven.
-
Use of the new tax-free dividend capacity.
Without them, the stock is likely to stay range-bound. The main supports are a 5%+ yield and steady buybacks, while customer concentration and low float limit upside.
Net view: asymmetric but slow-burning value. Downside is cushioned by tangible book of about KRW 13,200 per share and a cash-return programme that is becoming institutionalised. Upside depends on operational proof points that a single quarter (2Q26) has only begun to provide. Investors should monitor:
-
3Q26 gross margin
-
the Indonesian subsidiary's results in the FY2026 business report
-
any formal medium-term shareholder-return policy disclosure, which would materially lower the governance discount
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Tenure | Prior roles / background | Age | 2025 compensation |
|---|---|---|---|---|---|
Kim Han-jun (김한준) | CEO and Representative Director; largest shareholder (34.84%) | — | Member of the founding/controlling family | 52 (per Investing.com) | KRW 0.71 bn total (only individually disclosed executive) |
Jeon Je-hyung (전제형) | Co-Representative Director (each acts separately) | — | — | — | Below KRW 0.5 bn individual disclosure threshold (not disclosed) |
Kim Sang-hwa (김상화) | Director | — | — | 84 (per Investing.com) | Not individually disclosed |
Choi Do-yeol (최도열) | Independent Outside Director | — | — | 72 (per Investing.com) | Not individually disclosed |
Cho Yun-young (조윤영) | Executive Vice President (전무) of BAIKSAN since 1 Jan 2024; CEO of BS Research | Since Jan 2024 | CEO of bio-related subsidiary BS Research | — | Not individually disclosed. Personally bought 135,000 shares (about KRW 1.4 bn) in Dec 2023 and 20,000 shares in Jan 2024; stake 0.69% then, 0.75% at YE2025 |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
1 Jan 2024 | Cho Yun-young appointed Executive Vice President | Head of BS Research brought into parent management; followed by personal share purchases |
Major Shareholders
| Holder | Relationship | Stake (%) | As of |
|---|---|---|---|
Kim Han-jun | Largest shareholder (CEO) | 34.84 | 31 Dec 2025 |
Kim Mi-yeon | Relative | 12.25 | 31 Dec 2025 |
Kim Han-seong | Relative | 7.57 | 31 Dec 2025 |
Kim Jin-woo | Relative | 1.86 | 31 Dec 2025 |
Gu Da-hoe | Relative | 1.46 | 31 Dec 2025 |
Cho Yun-young | Other related party (executive) | 0.75 | 31 Dec 2025 |
Kim Jeong-woo | Relative | 0.44 | 31 Dec 2025 |
Kim Seo-hee | Relative | 0.25 | 31 Dec 2025 |
Jeon Je-hyung | Other related party (co-CEO) | 0.10 | 31 Dec 2025 |
Controlling group total | — | 59.53 | 31 Dec 2025 |
Controlling group total (latest) | — | 61.88 | 12 Aug 2026 filing |
VIP Asset Management | Institutional (5%+ holder) | 15.16 | Filed 27 Mar 2026 |
National Pension Service | Institutional | 2.92 | 31 Dec 2024 |
Shareholding Trend
| Controlling group stake (%) | Nov 2021 | 2022 | 2023 | 2024 | 2025 | Aug 2026 |
|---|---|---|---|---|---|---|
Kim Han-jun and related parties | 52.04 | 53.1 | 55.56 | 57.67 | 59.53 | 61.88 |
Competitive Landscape
Key Competitors
| Competitor | Listing | Home | Segment overlap | Latest revenue (local) | Positioning vs BAIKSAN |
|---|---|---|---|---|---|
San Fang Chemical Industry | TWSE: 1307 | Taiwan | Footwear PU synthetic leather (core), apparel films, automotive | FY2025 revenue about NT$10.8 bn; gross profit about NT$3.4 bn (GM about 31%); FY2024 net income NT$1.48 bn | Global leader with an estimated share above 40% of PU synthetic leather (local research estimate); footwear about 93% of FY2024 revenue; main customers include Nike, New Balance, Adidas, Puma, On; largest capacity in Vietnam |
Duksung Co., Ltd. | KOSPI: 004830 | Korea | Synthetic leather (sports goods, furniture, automotive, IT accessories), resins | FY2025 revenue KRW 146.5 bn; operating income KRW 6.2 bn; net income KRW 5.5 bn | Korea's oldest synthetic-leather maker (founded 1966); plants in Korea, Guangzhou and Ho Chi Minh City; building in Indonesia; about one-third of BAIKSAN's revenue with far lower margins |
Daewon Chemical (대원화성) | — | Korea | Synthetic leather | — | Named by Korean advisers (2012) as a domestic competitor BAIKSAN outperforms in capacity and quality |
Xingye Leather Technology | SZSE: 002674 | China | Leather and synthetic materials | — | Listed by Shinhan (2019) in BAIKSAN's peer set |
Anhui Anli Material Technology | SZSE: 300218 | China | PU synthetic leather (footwear, furniture, auto) | — | — |
Huafon Microfibre | SZSE: 300180 | China | Microfibre synthetic leather | — | — |
Kuraray (Clarino) | TSE: 3405 | Japan | Premium microfibre artificial leather (footwear, goods) | — | Premium and technology leader in nonwoven microfibre leather |
Toray Industries (Ultrasuede) / Teijin (Cordley) / Asahi Kasei (Lamous) | TSE | Japan | Premium suede-type and microfibre materials, automotive interiors | — | High-end, technology-led competitors in automotive and fashion |
Continental (surface solutions, formerly Benecke-Kaliko) | XETRA: CON (parent) | Germany | Automotive synthetic leather / surfaces | — | Global automotive interior-surface leader; competes for OEM programmes |
Hwaseung Enterprise | KOSPI: 241590 | Korea | Footwear OEM (customer-side peer) | — | Listed by Shinhan (2019) in BAIKSAN's comparison set; a shoemaker and potential customer rather than a direct competitor |
Peer Comparison FY2025
| Metric | BAIKSAN (FY2025) | San Fang Chemical (FY2025) | Duksung (FY2025) |
|---|---|---|---|
Revenue (local currency, bn) | KRW 504.9 | NT$10.8 | KRW 146.5 |
Revenue growth YoY (%) | 1.6 | about 0 (NT$10.78 bn in FY2024) | 16.8 |
Gross margin (%) | 21.7 | about 31 | — |
Operating margin (%) | 10.6 | — | 4.3 |
Net margin (%) | 6.6 | — | 3.7 |
P/E (x, recent) | about 5.6–5.8 | about 9.2 | about 15.3 |
P/B (x, recent) | about 0.74–0.76 | — | about 0.56 |
EV/EBITDA (x, recent) | about 4.3 | about 5.4 | — |
Recent Developments
Public newsflow for BAIKSAN consists mainly of regulatory disclosures. Fewer than the requested 25 were available in public sources for this period.
Items not found in the period: * no litigation, regulatory action, guidance revision, restructuring or layoff announcement, contract-win press release or leadership change was identified in public sources.



